Why is Samrat Pharma falling/rising?

As of 13-Oct, Samrat Pharmachem Ltd's stock price is currently at Rs 297.25, reflecting a decrease of Rs 6.95, or 2.28%. The stock has underperformed significantly, with a one-week return of -3.18% and a one-month return of -8.96%. It is also trading close to its 52-week low, just 2.78% above Rs 289. The stock has been consistently trading below its moving averages across various time frames, indicating a bearish trend. Despite a notable increase in delivery volume, which rose by 277.76% against the five-day average, there are no positive factors indicated in the dashboard that could counteract the negative price movement.
Broader market context shows that while the Sensex has gained 0.66% over the past week, Samrat Pharmachem's performance has been in stark contrast, highlighting its struggles in the current market environment. The stock's year-to-date decline of 22.20% and a staggering 46.15% drop over the past year further emphasize its underperformance compared to the benchmark, which has seen a modest gain of 5.36% during the same period. This divergence suggests that investor sentiment towards Samrat Pharmachem is weak, contributing to its declining stock price amidst a generally stable market backdrop.